General Court (President of the Chamber) 4 August 2022, T-278/22 R (Biogen Netherlands BV v European Commission.)

ORDER OF THE PRESIDENT OF THE GENERAL COURT 4 August 2022 (*) (Interim relief – Medicinal products for human use – Regulation (EC) No 726/2004 – Marketing authorisation for Dimethyl fumarate Neuraxpharm – dimethyl fumarate – Application for suspension of operation of a measure – No urgency) In Case T‑278/22 R, Biogen Netherlands BV, established in Badhoevedorp (Netherlands), represented by C.